Jacobs Levy Equity Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Jacobs Levy Equity Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-531,673	Closed	-$18.9M	–	1112
2023 Q1	$18.9M	Buy	531,673 +411,393	+342%	+$14.9M	0.12%	199
2022 Q4	$4.41M	Buy	120,280 +21,324	+22%	+$843K	0.03%	417
2022 Q3	$4.67M	Buy	+98,956	New	+$6.39M	0.04%	405
2022 Q2	–	Sell	-7,620	Closed	-$617K	–	1120
2022 Q1	$617K	Buy	+7,620	New	+$645K	﹤0.01%	833
2021 Q3	–	Sell	-9,786	Closed	-$876K	–	1148
2021 Q2	$876K	Buy	+9,786	New	+$827K	0.01%	765
2016 Q1	–	Sell	-7,030	Closed	-$341K	–	1195
2015 Q4	$341K	Hold	7,030	–	–	0.01%	630
2015 Q3	$281K	Hold	7,030	–	–	0.01%	666
2015 Q2	$282K	Buy	+7,030	New	+$243K	0.01%	670

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jacobs Levy Equity Management's SYNH Position: Q2 2023 in Review

Jacobs Levy Equity Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 531,673 shares — an estimated $18.9M sold.

Jacobs Levy Equity Management first reported a position in SYNH in Q2 2015 and held it in 8 quarters. The position peaked at $18.9M in Q1 2023. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

Jacobs Levy Equity Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Jacobs Levy Equity Management sold 531,673 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $18.9M.
Jacobs Levy Equity Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 8 quarters.
Jacobs Levy Equity Management's Syneos Health, Inc. Class A Common Stock position peaked at $18.9M in Q1 2023.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2023, filed 14 Aug 2023.